Publications by authors named "Ned Rupp"

Claim this Profile
L
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C Oriel, Ned Rupp

J Allergy Clin Immunol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C Oriel, Ned Rupp

J Allergy Clin Immunol Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Brian P Vickery, Andrea Vereda, Caroline Nilsson, George du Toit, Wayne G Shreffler, Ned T Rupp

J Allergy Clin Immunol Pract· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AR101 Oral Immunotherapy for Peanut Allergy.

N Engl J Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
Elianne J L E Vrijlandt, Georges El Azzi, Mark Vandewalker, Ned Rupp, Thomas Harper

Lancet Respir Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
John M Weiler, Robert A Nathan, Ned T Rupp, Christopher J Kalberg, Amanda Emmett

Ann Allergy Asthma Immunol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis